NEO
NeoGenomics, Inc. NASDAQ Listed Mar 16, 2004$9.08
Mkt Cap $236.5M
52w Low $4.72
48.3% of range
52w High $13.74
50d MA $8.43
200d MA $9.45
P/E (TTM)
-2.2x
EV/EBITDA
351.8x
P/B
0.3x
Debt/Equity
0.6x
ROE
-12.0%
P/FCF
-13.8x
RSI (14)
—
ATR (14)
—
Beta
1.71
50d MA
$8.43
200d MA
$9.45
Avg Volume
2.1M
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
9490 NeoGenomics Way · Fort Myers, FL 33912 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | 0.01 | 0.01 | +72.7% | 9.02 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -2.3% | — |
| Feb 17, 2026 | AMC | 0.04 | 0.06 | +50.0% | 11.44 | -0.3% | -10.3% | -2.4% | -1.2% | +0.8% | -3.2% | — |
| Oct 28, 2025 | AMC | 0.02 | 0.03 | +50.0% | 9.92 | +1.9% | +3.6% | -5.7% | +0.8% | +0.1% | +3.3% | — |
| Jul 29, 2025 | AMC | 0.03 | 0.03 | +0.0% | 5.25 | -0.6% | -2.9% | -5.1% | +6.6% | +9.9% | -0.9% | — |
| Apr 29, 2025 | AMC | -0.02 | -0.08 | -300.0% | 6.58 | -1.7% | -2.7% | +13.4% | +6.1% | +1.8% | -1.9% | — |
| Feb 18, 2025 | AMC | 0.03 | 0.04 | +33.3% | 12.41 | -1.6% | +2.5% | -6.8% | -6.4% | +0.6% | -2.6% | — |
| Nov 5, 2024 | AMC | 0.01 | 0.05 | +316.7% | 14.93 | +5.0% | +3.5% | +2.3% | -0.3% | +3.7% | -0.1% | — |
| Jul 29, 2024 | AMC | 0.00 | 0.03 | +879.1% | 14.64 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% | — |
| Apr 30, 2024 | AMC | -0.01 | -0.02 | -58.9% | 13.92 | +0.6% | +0.3% | +5.4% | +3.9% | +1.4% | +0.4% | — |
| Feb 20, 2024 | AMC | 0.01 | 0.03 | +220.1% | 14.70 | +11.6% | +12.1% | -0.2% | +2.1% | -3.1% | -0.9% | — |
| Nov 6, 2023 | AMC | -0.07 | -0.06 | +14.3% | 14.65 | +9.2% | +14.2% | -5.4% | -0.7% | +0.3% | +2.0% | — |
| Aug 8, 2023 | AMC | -0.10 | -0.05 | +50.0% | 15.32 | -0.2% | -3.3% | -4.8% | -0.3% | -0.9% | -3.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Benchmark | Upgrade | Hold → Buy | — | $9.02 | $10.25 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -1.6% |
| Apr 29 | TD Cowen | Maintains | Buy → Buy | — | $9.02 | $10.25 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -1.6% |
| Apr 29 | Leerink Partners | Upgrade | Market Perform → Outperform | $25 | $9.02 | $10.25 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -1.6% |
| Feb 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.97 | $10.18 | +2.1% | -3.2% | +1.8% | +3.6% | -3.3% | -3.4% |
| Feb 17 | Needham | Maintains | Buy → Buy | — | $11.38 | $10.50 | -7.7% | +0.5% | -10.3% | -2.4% | -1.2% | +0.8% |
| Jan 12 | Needham | Maintains | Buy → Buy | — | $13.16 | $13.26 | +0.8% | -5.1% | +3.5% | +2.2% | -3.0% | -0.3% |
| Sep 12 | TD Cowen | Maintains | Buy → Buy | — | $8.34 | $8.38 | +0.5% | -4.6% | +1.5% | -1.1% | +1.5% | +6.3% |
| Sep 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $8.78 | $8.76 | -0.2% | +0.3% | -7.0% | -1.6% | -1.0% | -0.6% |
| Aug 29 | Needham | Maintains | Buy → Buy | — | $7.21 | $8.78 | +21.8% | +21.8% | +0.3% | -7.0% | -1.6% | -1.0% |
| Aug 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.16 | $5.21 | +1.0% | +9.9% | -0.9% | -2.3% | +4.9% | +0.7% |
| Jul 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $5.25 | $5.22 | -0.6% | -2.9% | -5.1% | +6.6% | +9.9% | -0.9% |
| Jul 29 | Needham | Maintains | Buy → Buy | — | $6.46 | $5.30 | -18.0% | -18.7% | -2.9% | -5.1% | +6.6% | +9.9% |
| Jul 29 | William Blair | Downgrade | Outperform → Market Perform | — | $6.46 | $5.30 | -18.0% | -18.7% | -2.9% | -5.1% | +6.6% | +9.9% |
| May 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.84 | $7.83 | -0.1% | -1.9% | +4.0% | +1.6% | -1.0% | +5.7% |
| May 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.40 | $6.47 | +1.1% | +13.4% | +6.1% | +1.8% | -1.9% | +4.0% |
| Apr 30 | Goldman Sachs | Maintains | Buy → Buy | — | $6.58 | $6.47 | -1.7% | -2.7% | +13.4% | +6.1% | +1.8% | -1.9% |
| Apr 30 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $6.58 | $6.47 | -1.7% | -2.7% | +13.4% | +6.1% | +1.8% | -1.9% |
| Apr 29 | Needham | Maintains | Buy → Buy | — | $9.97 | $9.64 | -3.3% | -34.0% | -2.7% | +13.4% | +6.1% | +1.8% |
| Apr 17 | Goldman Sachs | Maintains | Buy → Buy | — | $9.56 | $9.50 | -0.6% | -0.1% | +0.3% | +1.8% | +1.6% | +1.8% |
| Feb 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.88 | $10.87 | -0.1% | -4.4% | -5.6% | +1.7% | -4.1% | -2.5% |
| Feb 19 | BofA Securities | Maintains | Neutral → Neutral | — | $12.41 | $12.21 | -1.6% | +2.5% | -6.8% | -6.4% | +0.6% | -2.6% |
| Feb 19 | Needham | Maintains | Buy → Buy | — | $12.41 | $12.21 | -1.6% | +2.5% | -6.8% | -6.4% | +0.6% | -2.6% |
| Jan 28 | Goldman Sachs | Maintains | Buy → Buy | — | $15.04 | $15.02 | -0.1% | +0.9% | -4.0% | +1.6% | -3.4% | -2.9% |
| Jan 16 | Benchmark | Maintains | Hold → Hold | — | $14.71 | $14.63 | -0.5% | -5.0% | +1.6% | -0.2% | +2.3% | +1.1% |
| Jan 15 | Needham | Maintains | Buy → Buy | — | $13.78 | $14.95 | +8.5% | +6.7% | -5.0% | +1.6% | -0.2% | +2.3% |
| Jan 13 | Benchmark | Downgrade | Buy → Hold | — | $14.77 | $14.11 | -4.5% | -14.5% | +9.1% | +6.7% | -5.0% | +1.6% |
| Jan 10 | Needham | Maintains | Buy → Buy | — | $18.61 | $17.75 | -4.6% | -20.6% | -14.5% | +9.1% | +6.7% | -5.0% |
| Dec 13 | BofA Securities | Maintains | Neutral → Neutral | — | $17.90 | $17.72 | -1.0% | -0.9% | +1.4% | -2.3% | -6.0% | -0.5% |
| Nov 6 | Needham | Maintains | Buy → Buy | — | $14.93 | $15.68 | +5.0% | +3.5% | +2.3% | -0.3% | +3.7% | -0.1% |
| Sep 25 | Needham | Maintains | Buy → Buy | — | $15.80 | $15.78 | -0.1% | -5.3% | -2.1% | -1.0% | +1.7% | -6.4% |
| Sep 24 | Benchmark | Maintains | Buy → Buy | — | $15.80 | $15.94 | +0.9% | +0.0% | -5.3% | -2.1% | -1.0% | +1.7% |
| Jul 30 | Needham | Maintains | Buy → Buy | — | $14.64 | $15.89 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% |
| Jul 30 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.64 | $15.89 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% |
| Jul 30 | Benchmark | Maintains | Buy → Buy | — | $14.64 | $15.89 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% |
| May 2 | BTIG | Maintains | Buy → Buy | — | $13.96 | $14.03 | +0.5% | +5.4% | +3.9% | +1.4% | +0.4% | -2.8% |
| May 1 | TD Cowen | Maintains | Buy → Buy | — | $13.92 | $14.00 | +0.6% | +0.3% | +5.4% | +3.9% | +1.4% | +0.4% |
| May 1 | Benchmark | Maintains | Buy → Buy | — | $13.92 | $14.00 | +0.6% | +0.3% | +5.4% | +3.9% | +1.4% | +0.4% |
| Apr 30 | Needham | Maintains | Buy → Buy | — | $15.22 | $14.92 | -2.0% | -8.5% | +0.3% | +5.4% | +3.9% | +1.4% |
| Feb 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $16.79 | $16.87 | +0.5% | -3.1% | -0.9% | -3.5% | +0.3% | +2.4% |
| Feb 22 | Goldman Sachs | Maintains | Buy → Buy | — | $16.48 | $16.69 | +1.3% | -0.2% | +2.1% | -3.1% | -0.9% | -3.5% |
| Feb 21 | Needham | Maintains | Buy → Buy | — | $14.70 | $16.40 | +11.6% | +12.1% | -0.2% | +2.1% | -3.1% | -0.9% |
| Dec 29 | TD Cowen | Maintains | Outperform → Outperform | — | $16.79 | $16.82 | +0.2% | -3.6% | -1.4% | +1.0% | -2.1% | -1.0% |
| Dec 29 | BTIG | Maintains | Buy → Buy | — | $16.79 | $16.82 | +0.2% | -3.6% | -1.4% | +1.0% | -2.1% | -1.0% |
| Dec 28 | Needham | Maintains | Buy → Buy | — | $20.50 | $18.05 | -12.0% | -18.1% | -3.6% | -1.4% | +1.0% | -2.1% |
| Nov 8 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $16.73 | $16.80 | +0.4% | -5.4% | -0.7% | +0.3% | +2.0% | +8.7% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $14.65 | $16.00 | +9.2% | +14.2% | -5.4% | -0.7% | +0.3% | +2.0% |
| Oct 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $13.71 | $13.76 | +0.4% | +7.6% | -1.2% | -0.4% | -6.2% | +0.0% |
| Oct 23 | Goldman Sachs | Maintains | Buy → Buy | — | $13.90 | $13.60 | -2.2% | -1.4% | +7.6% | -1.2% | -0.4% | -6.2% |
| Oct 20 | Goldman Sachs | Maintains | Buy → Buy | — | $13.77 | $13.81 | +0.3% | +0.9% | -1.4% | +7.6% | -1.2% | -0.4% |
| Oct 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.50 | $12.60 | +0.8% | +1.2% | +8.9% | -0.4% | +0.4% | +0.9% |
No insider trades available.
Data updated apr 26, 2026 2:39pm
· Source: massive.com